Managing people with sickle cell disease and complex chronic pain is difficult and requires some trial and error, said C. Patrick Carroll, MD, director of psychiatric services, Sickle Cell Center for Adults, associate professor of psychiatry, Johns Hopkins Medicine.
Managing people with sickle cell disease and complex chronic pain is difficult and requires some trial and error, said C. Patrick Carroll, MD, director of psychiatric services, Sickle Cell Center for Adults, associate professor of psychiatry, Johns Hopkins Medicine.
Transcript
For patients with sickle cell disease who have the highest levels of pain, what treatment options need to be considered if their pain is not properly managed?
Well, the highest levels of pain in the question is tricky, because sickle cell disease can produce all manner of pain with all kinds of time courses. So, you can have some people who have intermittent crisis pain or acute pain. And then there are people who have very frequent crises. And then there are people who have chronic pain, and sometimes that can be from a complication of sickle cell disease, like avascular necrosis, and sometimes you can't find any particular cause for it, except that they have sickle cell disease. And then you can have any combination of those.
And so, much depends on the actual clinical situation. So, if you have someone who's having frequent crises, the first thing is can you manage the sickle cell disease any better? One of the questions I'm often asking my team is, are we treating this patient for crises they shouldn't be happening? Are they on hydroxyurea? Are they getting any other former disease-modifying therapy? Or are they worth a try on chronic transfusion therapy? Anything we can do to try to help the acute pain, prevent it, but also to help shift people more towards an outpatient care strategy with a multidisciplinary team rather than being cared for in emergency rooms and inpatient hospitals.
And then if you can achieve that, the question it really depends on what's been tried and what has failed. And I am a big fan of declaring failure when things haven’t worked. So, if a person's been treated in a particular way, it doesn't seem to have worked, then the thing to often do is to stop doing that rather than do more of it and try something different. But the evidence base behind any treatments for chronic pain in particular is very poor. And so, we're very much in a trial-and-error process more trying to manage people with complex chronic pain.
Persistence Pays Off With Zanubrutinib: A Challenging CLL Case With a Prior BTK Inhibitor Failure
May 10th 2024The case of a 77-year-old woman with a long chronic lymphocytic leukemia (CLL) history illustrates the novel use of zanubrutinib as a potential option for some patients who have failed first-generation Bruton tyrosine kinase (BTK) inhibitors and venetoclax.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More